Clinical Trials · NCT07884201
Thymalfasin Combined With Chemotherapy and Immunotherapy in TNBC Neoadjuvant Treatment
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Fudan University
- Enrollment
- 572
- Start date
- Nov 2026
- Locations
- See registry
- Primary endpoint
- EFS